title: Prophylaxis with a short course of OKT3 in renal transplantation: comparative analysis with recipients treated either with prophylactic ATG or with CyA.
authors.affiliation: Department of Nephrology, Hospital de l'Esperança, Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Lloveras
authors.forename: J M
authors.initials: JM
authors.lastname: Puig
authors.forename: A
authors.initials: A
authors.lastname: Oliveras
authors.forename: A
authors.initials: A
authors.lastname: Orfila
authors.forename: I
authors.initials: I
authors.lastname: Comerma
authors.forename: J
authors.initials: J
authors.lastname: Aubia
authors.forename: J
authors.initials: J
authors.lastname: Masramón
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D016572:Cyclosporine